HHealthcare Read More LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugsDecember 30, 2025 NEW YORK, December 29, 2025, 17:45 ET — After-hours Shares of Eli Lilly and Company (LLY) were up…
HHealthcare Read More STAT staffers share stories they wish they had written in 2025December 30, 2025 This year saw upheaval in all corners of health, science, and biotech. While our staff was covering all…
HHealthcare Read More U.S. vaccine policy could see big changes in 2026December 24, 2025 WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of…
EEntrepreneurship Read More Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mnDecember 23, 2025 Plasmagen Biosciences CEO Vivek Kamath PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures…
MMedication Read More Nasal spray sold nationwide recalled. See impacted products.December 21, 2025 Something you bought was just recalled. What does that mean? What happens when something you purchase is recalled?…
MMedication Read More Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)December 19, 2025 Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
MMedication Read More FDA voucher program has led to political interference in drug reviews, staffers sayDecember 19, 2025 WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
MMedication Read More Meta urged by state AGs to regulate weight loss drug adsDecember 18, 2025 More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
HHealthcare Read More Pfizer 2026 guidance shows Metsera, Seagen deals will take time to pay offDecember 17, 2025 Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks…
HHealthcare Read More Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in AlabamaDecember 13, 2025 Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly’s oral GLP-1,…
HHealthcare Read More Eli Lilly to build $6 billion Alabama manufacturing plantDecember 9, 2025 Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept.…
HHealthcare Read More Health insurer prescription costs rise 20%, GLP-1s cited as causeDecember 8, 2025 Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…